1. Home
  2. EXPI vs NEO Comparison

EXPI vs NEO Comparison

Compare EXPI & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPI
  • NEO
  • Stock Information
  • Founded
  • EXPI 2008
  • NEO 2001
  • Country
  • EXPI United States
  • NEO United States
  • Employees
  • EXPI N/A
  • NEO N/A
  • Industry
  • EXPI Real Estate
  • NEO Precision Instruments
  • Sector
  • EXPI Finance
  • NEO Health Care
  • Exchange
  • EXPI Nasdaq
  • NEO Nasdaq
  • Market Cap
  • EXPI 2.0B
  • NEO 2.3B
  • IPO Year
  • EXPI N/A
  • NEO 1999
  • Fundamental
  • Price
  • EXPI $12.81
  • NEO $16.53
  • Analyst Decision
  • EXPI Hold
  • NEO Strong Buy
  • Analyst Count
  • EXPI 2
  • NEO 10
  • Target Price
  • EXPI $13.50
  • NEO $20.30
  • AVG Volume (30 Days)
  • EXPI 1.3M
  • NEO 765.3K
  • Earning Date
  • EXPI 02-20-2025
  • NEO 02-18-2025
  • Dividend Yield
  • EXPI 1.56%
  • NEO N/A
  • EPS Growth
  • EXPI N/A
  • NEO N/A
  • EPS
  • EXPI N/A
  • NEO N/A
  • Revenue
  • EXPI $4,458,228,000.00
  • NEO $644,118,000.00
  • Revenue This Year
  • EXPI $7.24
  • NEO $12.98
  • Revenue Next Year
  • EXPI $7.69
  • NEO $9.83
  • P/E Ratio
  • EXPI N/A
  • NEO N/A
  • Revenue Growth
  • EXPI 5.50
  • NEO 12.06
  • 52 Week Low
  • EXPI $8.91
  • NEO $12.77
  • 52 Week High
  • EXPI $16.48
  • NEO $21.22
  • Technical
  • Relative Strength Index (RSI)
  • EXPI 47.15
  • NEO 44.50
  • Support Level
  • EXPI $12.49
  • NEO $17.24
  • Resistance Level
  • EXPI $13.07
  • NEO $18.20
  • Average True Range (ATR)
  • EXPI 0.67
  • NEO 0.70
  • MACD
  • EXPI -0.13
  • NEO -0.28
  • Stochastic Oscillator
  • EXPI 51.45
  • NEO 6.41

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

Share on Social Networks: